Seong Kyu Han Selected Research

Facial Pain (Myofacial Pain)

11/2022	Resveratrol activates GABAA and/or glycine receptors on substantia gelatinosa neurons of the subnucleus caudalis in mice.
1/2021	GABA- and Glycine-Mimetic Responses of Linalool on the Substantia Gelatinosa of the Trigeminal Subnucleus Caudalis in Juvenile Mice: Pain Management through Linalool-Mediated Inhibitory Neurotransmission.
9/2020	Inhibitory actions of borneol on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice.
9/2019	Action of citral on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in juvenile mice.
12/2016	Effects of hypotaurine on substantia gelatinosa neurons of the trigeminal subnucleus caudalis in immature mice.
1/2016	Baicalin Activates Glycine and γ-Aminobutyric Acid Receptors on Substantia Gelatinosa Neurons of the Trigeminal Subsnucleus Caudalis in Juvenile Mice.
7/2015	Enhanced GABA action on the substantia gelatinosa neurons of the medullary dorsal horn in the offspring of streptozotocin-injected mice.
1/2013	Activation of glycine and extrasynaptic GABA(A) receptors by taurine on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis.
10/2011	Glycine- and GABA-mimetic Actions of Shilajit on the Substantia Gelatinosa Neurons of the Trigeminal Subnucleus Caudalis in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seong Kyu Han Research Topics

Disease

9	Facial Pain (Myofacial Pain) 11/2022 - 10/2011
3	Pain (Aches) 01/2017 - 10/2011
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2013 - 01/2012
2	Neoplasms (Cancer) 10/2020 - 01/2016
1	Mental Disorders (Mental Disorder) 04/2021
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020
1	Memory Disorders (Memory Loss) 07/2018
1	Dementia (Dementias) 07/2018
1	Cognitive Dysfunction 07/2018
1	Bone Resorption 04/2017
1	Hyperalgesia 01/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Diabetic Neuropathies (Diabetic Neuropathy) 07/2015
1	Body Weight (Weight, Body) 07/2015
1	Myocardial Infarction 10/2010

Drug/Important Bio-Agent (IBA)

6	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2013
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021 - 09/2019
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2020 - 01/2016
2	MagnesiumIBA 04/2012 - 01/2012
1	ResveratrolIBA 11/2022
1	SaltsIBA 04/2021
1	Therapeutic UsesIBA 04/2021
1	LithiumIBA 04/2021
1	linaloolIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2020
1	isoborneol (borneol)IBA 09/2020
1	citral (neral)IBA 09/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2018
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 07/2018
1	Cholinergic Agents (Cholinergics)IBA 07/2018
1	Adenosine Triphosphate (ATP)IBA 04/2017
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2017
1	BicucullineIBA 01/2017
1	Sodium-Potassium-Chloride SymportersIBA 01/2017
1	Bumetanide (Bumex)FDA LinkGeneric 01/2017
1	Glycine Receptors (Glycine Receptor)IBA 12/2016
1	hypotaurineIBA 12/2016
1	PlatinumIBA 01/2016
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	baicalinIBA 01/2016
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 07/2015
1	Blood Glucose (Blood Sugar)IBA 07/2015
1	Vasodilator Agents (Vasodilators)IBA 05/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2013
1	Taurine FDA Link 01/2013
1	Amino Acids FDA Link 01/2013
1	mumieIBA 10/2011
1	Crystallins (Crystallin)IBA 10/2010

Therapy/Procedure

2	Therapeutics 04/2021 - 12/2016
1	Subcutaneous Injections 01/2017
1	Injections 07/2015